McKesson Ventures
  • Portfolio
  • News
  • Team
  • About Us
    • Our Approach
    • About McKesson
    • Contact Us

Aster Insights Announces Research Partnership with FDA to Study the Effects of Patient Demographics on Diagnostic Indicators Used for Checkpoint Inhibitor Therapy

by McKesson Ventures | Apr 8, 2024 | Press Releases

On Monday, April 8, 2024, Florida-based biotechnology research company Aster Insights announced that it has partnered with the Food & Drug Administration (FDA) to examine the relationship between the scoring algorithms used in diagnostic testing and key patient...

Recent Posts

  • Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies
  • Prudentia Sciences Announces Series A Led by McKesson Ventures, Accelerating Due Diligence for Life Sciences Dealmaking
  • Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
  • Midi Health CEO Joanna Strober Discusses Accessible Menopause Care with McKesson Ventures Partner Michelle Snyder on Breaking Health Podcast
  • Atropos Health Launches the Atropos Evidenceā„¢ Agent with Microsoft Teams to Surface Personalized Evidence during Multidisciplinary Care Team Collaborations
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

IN THE NEWS

ABOUT US

CONTACT US

  • Follow
©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings
McKesson Ventures

One Post Street, 21st Floor
San Francisco, CA 94104

©2026 McKesson Ventures | Privacy Notice | Disclaimer | Cookie Settings